Fever-An update

Journal of the American Podiatric Medical Association

Volumn 100, Issue 4, 2010, Pages 281-290

  Becker, John H ^a   Wu, Stephanie C ^b  

^a Rosalind Franklin University of Medicine and Science Dr William M Scholl College of Podiatric Medicine   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650274544     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/1000281     Document Type: Review

References (129)

1. ATKINS E: Fever: new perspectives on an old phenomenon. N Engl J Med 308: 958, 1983.
2. ROMANOVSKY A: Thermoregulation: some concepts have changed: functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 292: R37, 2007.
3. COOPER KE: Fever and Antipyresis, Cambridge University Press, Cambridge, 1995.
4. SHARMA HS: Methods to produce hyperthermia-induced brain dysfunction. Prog Brain Res 162: 173, 2007.
5. IVANOV AI, PATEL S, KULCHITSKY VA, ET AL: Plateletactivating factor: a previously unrecognized mediator of fever. J Physiol 553: 221, 2003.
6. DINARELLO C, PORAT R: "Fever and Hypothermia," in Harrison's Principles of Internal Medicine, 17th Ed, ed by AS Fauci, p 117, McGraw Hill, New York, 2008.
7. ROTH J, RUMMEL C, BARTH SW, ET AL: Molecular aspects of fever. Neurol Clin 24: 421, 2006.
8. BLATTEIS CM, SEHIC E: Fever: how may circulating pyrogens signal the brain? News Physiol Sci 12: 1, 1997.
9. KOZAK W, KLUGER MJ, SOSZYNSKI D, ET AL: "IL-6 and IL-1b in Fever: Studies UsingCytokine-Deficient (Knockout) Mice," in Molecular Mechanisms in Fever, Vol 856, ed by MJ Kluger, p 33, New York Academy of Sciences, New York, 1998.
10. OOTSUKA Y, BLESSING WW, STEINER AA, ET AL: Fever response to intravenous prostaglandin E2 is mediated by the brain but does not require afferent vagal signaling. Am J Physiol Regul Integr Comp Physiol 294: R1294, 2008.
11. BLATTEIS C: The onset of fever: new insights into its mechanism. Prog Brain Res 162: 3, 2007.
12. MILTON AS, WENDLANDT S: Effects on body temperature of prostaglandins of the A, E, and F series on injection into the third ventricle of unanaesthetized cats and rabbits. J Physiol 218: 325, 1971.
13. 3. Nature 395: 281, 1998.
14. NAKAMURA K, MATSUMURA K, KANEKO T, ET AL: The rostral raphe pallidus nucleus mediates pyrogenic transmission from the preoptic area. J Neurosci 22: 4600, 2002.
15. MORRISON SF, NAKAMURA K, MADDEN CJ: Central control of thermogenesis in mammals. Exp Physiol 93: 773, 2008.
16. KLUGER MJ: Fever: role of pyrogens and cryogens. Physiol Rev 71: 93, 1991.
17. DUBOIS E: Why are fever temperatures over 106 degrees F rare? Am J Med Sci 217: 361, 1949.
18. BOUCHAMA A, KNOCHEL JP: Heat stroke. N Engl J Med 346: 1978, 2002.
19. COOPER K, NAYLOR AM, VEALE WL: Evidence supporting a role for endogenous vasopressin in fever suppression in the rat. J Physiol 387: 163, 1987.
20. SINHA P, SCHIOTH HB, TATRO JB: Activation of central melanocortin-4 receptor suppresses lipopolysaccharide-induced fever in rats. Am J Physiol Regul Integr Comp Physiol 284: R1595, 2003.
21. MIYOSHI M, KITAGAWA Y, IMOTO T, ET AL: Effect of natriuretic peptide receptor antagonist on lipopolysaccharide-induced fever in rats: is natriuretic peptide an endogenous antipyretic? J Pharmacol Exp Ther 318: 1163, 2006.
22. MORROW LE, MCCLELLAN JL, CONN CA, ET AL: Glucocorticoids alter fever and IL-6 responses to psychological stress and to LPS. Am J Physiol 264: R1010, 1993.
23. MEDZHITOV R, JANEWAY C: Innate immunity. N Engl J Med 343: 338, 2000.
24. SABROE I, PARKER LC, DOWER SK, ET AL: The role of TLR activation in inflammation. J Pathol 214: 126, 2008.
25. DINARELLO CA: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 10: 201, 2004.
26. DINARELLO CA, WOLFF SM: "Exogenous Pyrogens," in Pyretics and Antipyretics, ed by AS Milton, p 73, Springer-Verlag, Berlin, 1982.
27. SWARTZ MN, SIMON HB: "Pathophysiology of Fever and Fever of Undetermined Origin," in Scientific American Medicine, Vol 7, p 1, Freeman, San Francisco, 1992.
28. AREND WP, DAYER JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305, 1990.
29. ELLIOTT MJ, MAINI RN, FELDMANN M, ET AL: Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105, 1994.
30. MOLTZ H: Fever: causes and consequences. Neurosci Biobehav Rev 17: 237, 1993.
31. HASAN MK, WHITE AC: Psychogenic fever: entity or nonentity? Postgrad Med 66: 152, 1979.
32. OKA T, OKA K, HORI T: Mechanisms and mediators of psychological stress-induced risein core temperature. Psychosom Med 63: 476, 2001.
33. GORDON C, ROWSEY P: Poisons and fever. Clin Exp Pharmacol Physiol 25: 145, 1998.
34. ZELL JA, CHANG JC: Neoplastic fever: a neglected paraneoplastic syndrome. Support Care Cancer 13: 870, 2005.
35. DINARELLO C, BUNN P: Fever. Semin Oncol 24: 288, 1997.
36. CHANG JC: Neoplastic fever: a proposal for diagnosis. Arch Intern Med 149: 1728, 1989
37. PETERSDORF RG: Fever of unknown origin: an old friend revisited. Ann Intern Med 152: 21, 1992.
38. CUNHA B: Fever of unknown origin: clinical overview of classic and current concepts. Infect Dis Clin North Am 21: 867, 2007.
39. KNOCKAERT DC, VANDERSCHUEREN S, BLOCKMANS D: Fever of unknown origin in adults: 40 years on. J Intern Med 253: 263, 2003.
40. ARNOW PM, FLAHERTY JP: Fever of unknown origin. Lancet 350: 575, 1997.
41. DURACK DT: "Fever of Unknown Origin," in Fever: Basic Mechanisms and Management, 2nd Ed, ed by PA Mackowiak, p 237, Lippincott-Raven, Philadelphia, 1997.
42. HANSON MA: Drug fever: remember to consider it in diagnosis. Postgrad Med 89: 167, 1991.
43. EYER F, ZILKER T: Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity. Crit Care 11: 236, 2007.
44. CUNHA BA: Drug fever: the importance of recognition. Postgrad Med 80: 123, 1986.
45. NISIJIMA K, SHIODA K, IWAMURA T: Neuroleptic malignant syndrome and serotonin syndrome. Prog Brain Res 162: 81, 2007.
46. MUELLER P, KOREY W: Death by "ecstasy": the serotonin syndrome? Ann Emerg Med 32: 377, 1998.
47. ROSENBERG H, SEITMAN D: "Pharmacogenetics," in Clinical Anesthesia, ed byPG Barash, BF Cullen, RK Stoelting, p 459, JB Lippincott, Philadelphia, 1989.
48. DYKSTRA TJ, MENOLASINO MJ: Neuroleptic malignant syndrome: case report and review. J Am Osteopath Assoc 97: 355, 1997.
49. MUSHER DM, FAINSTEIN V, YOUNG EJ, ET AL: Fever patterns: their lack of clinical significance. Arch Intern Med 139: 1225, 1979.
50. WOODWARD TE: "The Fever Pattern as a Diagnostic Aid," in Fever: Basic Mechanisms and Management, 2nd Ed, ed by PA Mackowiak, p 215, Lippincott-Raven, Philadelphia, 1997.
51. SESSLER D: Temperature monitoring and perioperative thermoregulation. Anesthesiology 109: 318, 2008.
52. MCCARTHY PW, HEUSCH AI: The vagaries of ear temperature assessment. J Med Eng Technol 30: 242, 2006.
53. MACKOWIAK PA, WASSERMAN SS, LEVIN MM: A critical appraisal of 98.6°F, the upperlimit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich.JAMA 268: 1578, 1992.
54. HENKER R, CARLSON KK: Fever: applying research to bedside practice. AACN Adv Crit Care 18: 76, 2007.
55. CUNHA BA: The clinical significance of fever patterns. Infect Dis Clin North Am 10:33, 1996.
56. TUNNESSEN WW: Signs and Symptoms in Pediatrics, Lippincott Williams & Wilkins, Philadelphia, 1999.
57. SCHMITT B: Fever phobia: misconceptions of parents about fevers. Am J Dis Child 134: 176, 1980.
58. CROCETTI M, MOGHBELI N, SERWINT J: Fever phobia revisited: have parental misconceptions about fever changed in 20 years? Pediatrics 107: 1241, 2001.
59. HASLAM RH: "Febrile Seizures," in Nelson Textbook of Pediatrics, 18th Ed,ed by RM Kliegman, RE Behrman, HB Jenson, et al, p 2457, Saunders, Philadelphia, 2007.
60. KNUDSEN FU: Febrile seizures: treatment and prognosis. Epilepsia 41: 2, 2000.
61. BAUMANN RJ: Technical report: treatment of the child with simple febrile seizures. Pediatrics 103: e86, 1999.
62. APPLEGATE MS, LO W: Febrile seizures: current concepts concerning prognosis and clinical management. J Fam Pract 29: 422, 1989.
63. KLUGER MJ: Fever revisited. Pediatrics 90: 846, 1992.
64. UHARI M, RANTALA H, VAINIONPAA L, ET AL: Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr 126: 991, 1995.
65. FETVEIT A: Assessment of febrile seizures in children. Eur J Pediatr 167: 17, 2008.
66. NORMAN DC, WONG MB, YOSHIKAWA TT: Fever of unknown origin in older persons. Infect Dis Clin North Am 21: 937, 2007.
67. JONES SR: "Fever in the Elderly," in Fever: Basic Mechanisms and Management, 1st Ed, ed by PA Mackowiak, p 233, Raven Press, New York, 1991.
68. VANE J: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232, 1971.
69. SCHWARTZ JI, CHAN CC, MUKHOPADHYAY S, ET AL: Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 65: 653, 1999.
70. SOLOMON DH, SCHNEEWEISS S, GLYNN RJ, ET AL: Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109: 2068, 2004.
71. HINZ B, CHEREMINA O, BRUNE K: Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 22: 383, 2007.
72. ROMANOVSKY AA, ALMEIDA MC, ARONOFF DM, ET AL: Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci 10: 2193, 2005.
73. PLAISANCE KI, MACKOWIAK PA: Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Med 160: 449, 2000.
74. ISAACS SN, AXELROD PI, LORBER B: Antipyretic orders in a university hospital. Am J Med 88: 31, 1990.
75. THOMAS V, RIEGEL B, ANDREA J, ET AL: National survey of pediatric fever management practices among emergency department nurses. J Emerg Nurs 20: 505, 1994.
76. STYRT B, SUGARMAN B: Antipyresis and fever. Arch Intern Med 150: 1589, 1990.
77. GOZZOLI V, SCHOTTKER P, SUTER PM, ET AL: Is it worth treating fever in intensive care unit patients? Arch Intern Med 161: 121, 2001.
78. MACKOWIAK P: The febrile patient: diagnostic, prognostic and therapeutic considerations. Front Biosci 9: 2297, 2004.
79. FERGUSON A: Evaluation and treatment of fever in intensive care unit patients. CritCare Nurs Q 30: 347,2007
80. AXELROD YK, DIRINGER MN: Temperature management in acute neurologic disorders. Neurol Clin 26: 585, 2008.
81. KLUGER MJ: "The Adaptive Value of Fever," in Fever: Basic Mechanisms and Management, 1st Ed, ed by PA Mackowiak, p 105, Raven Press, New York, 1991.
82. ROBERTS NJ: Impact of temperature elevation on immunological defenses. Rev Infect Dis 13: 462, 1991.
83. OSTBERG JR, REPASKY EA: Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 55: 292, 2006.
84. HASDAY JD, GARRISON A: Antipyretic therapy in patients with sepsis. Clin Infect Dis31: S234, 2000.
85. MACKOWIAK PA, PLAISANCE KI: "Benefits and Risks of Antipyretic Therapy," in Molecular Mechanisms of Fever, Vol 856, ed by MJ Kluger, p 214, New York Academy of Sciences, New York, 1998.
86. WALSH A, EDWARDS H: Management of childhood fever by parents: literature review. J Adv Nurs 54: 217, 2006.
87. LINDER N, SIROTA L, SNAPIR A, ET AL: Parental knowledge of the treatment of fever in children. Israeli Med Assoc J 1: 158, 1999.
88. DORAN TF, DE ANGELIS C, BAUMGARDNER RA, ET AL: Acetaminophen: more harm than good for chickenpox? J Pediatr 114: 1045, 1989.
89. KRAMER MS, NAIMARK LE, ROBERTS-BRAUER R, ET AL: Risks and benefits of paracetamol antipyresis in young children with fever of presumed viral origin. Lancet 337: 591, 1991.
90. CASTEELS-VAN DAELE M: Management of childhood fever. Lancet 338: 1049, 1991.
91. POWELL KR: "Fever," in Nelson Textbook of Pediatrics, 18th Ed, ed by RM Kliegman, RE Behrman, HB Jenson, BM Stanton, p 1084, Saunders, Philadelphia, 2007.
92. KURZ A, SESSLER DI, LENHARDT R: Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 334: 1209, 1996.
93. FRANK SM, KLUGER MJ, KUNKEL SL: Elevated thermostatic setpoint in postoperative patients. Anesthesiology 93: 1426, 2000.
94. ENGOREN M: Lack of association between atelectasis and fever. Chest 107: 81, 1995.
95. DAYTON MT: "Surgical Complications," in Sabiston Textbook of Surgery, 17th Ed, ed by CM Townsend, p 297, Elsevier-Saunders, Philadelphia, 2005.
96. BALLESTAS HC: Postoperative fever: to what is the body really responding? AORN J 86: 983, 2007.
97. FISCHER JE, FEGELMAN E, JOHANNIGMAN J: "Surgical Complications," in Principles of Surgery, 7th Ed, ed by S Schwarts, p 447, McGraw-Hill, New York, 1999.
98. DIAMOND PT, MACCIOCHI SN: Predictive power of clinical symptoms in patients with presumptive deep venous thrombosis. Am J Physical Med Rehabil 76: 49, 1997.
99. KANG KH, LEE EY, LEE YJ, ET AL: Clinical features and risk factors of postsurgical gout. Ann Rheum Dis 67: 1271, 2008.
100. MARIK PE: Fever in the ICU. Chest 117: 855, 2000.
101. O'GRADY NP, BARIE PS, BARTLETT JG, ET AL: Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 36: 1330, 2008.
102. KENNEDY C, LEFOR AT: "Routine and Specialized Postoperative Care," in Perioperataive Care, Anesthesia, Medicine and Surgery, ed by DJ Stone, p 758, Mosby, St Louis, 1998.
103. LENHARDT R, NEGISHI C, SESSLER DI, ET AL: The effects of physical treatment on induced fever in humans. Am J Med 106: 550, 1999.
104. LARACH MG: Making Anesthesia Safer: Unraveling the Malignant Hyperthermia Puzzle, Federation of American Societies of Experimental Biology, Bethesda, MD, 2001.
105. DENBOROUGH M: Malignant hyperthermia. Lancet 352: 1131, 1998.
106. LARACH MG, BRANDOM BW, ALLEN GC, ET AL: Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States. Anesthesiology 108: 603, 2008.
107. ROSERO EB, ADESANYA AO, TIMARAN CH, ET AL: Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology 110: 89, 2009.
108. MACLENNAN DH, PHILLIPS MS: Malignant hyperthermia. Science 256: 789, 1992.
109. 2+ release channels. Am J Med 104: 470, 1998.
110. ROSENBERG H, DAVIS M, JAMES D, ET AL: Malignant hyperthermia. Orphanet J Rare Dis 2: 21, 2007.
111. DONNELLY AJ: Malignant hyperthermia. AORN J 59: 394, 1994.
112. HARRISON GG: Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesthesia 47: 62, 1975.
113. KRAUSE T, GERBERSHAGEN MU, FIEGE M, ET AL: Dantrolene: a review of its pharmacology, therapeutic use and new developments. Anaesthesia 59: 364, 2004.
114. JOSEPH WS: "Infections," in Principles and Practice of Podiatric Medicine, ed by LA Levy, VJ Hetherington, p 277, Churchill- Livingstone, New York, 1990.
115. DUFF GW, ATKINS E, MALAWISTA SE: The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians 96: 234, 1983.
116. DENNO GJ, ed: Podiatric Therapeutic Digest, 3rd Ed, Odontos Publishing, Eastlake, OH, 1999.
117. DONOGHUE S: Fighting for every dollar. Podiatry Manage 28: 97, 2009.
118. SULLI MM, ETZEL JV: Using of non-steroidal antiinflammatory drugs. Podiatry Manage21: 109, 2000.
119. MILLER SJ: Temperature regulation and postoperative fever: a preliminary study. JAPA 74: 373, 1984.
120. STRENGE KB, MANGAN DB, IDUSUYI OB: Postoperative toxic shock syndrome after excision of a ganglion cyst from the ankle. J Foot Ankle Surg 45: 275, 2006.
121. BOEGEL WA, MILLER SJ: "Perioperative Considerations for Foot and Ankle Surgery," in Comprehensive Textbook of Foot Surgery, 2nd Ed, ed by ED McGlamry, AS Banks, MD Downey, p 181, Williams & Wilkins, Baltimore, 1992.
122. GRONEN WW, RODA PL: Malignant hyperthermia: a case report. JAPA 66: 31, 1976.
123. GOHIL B, FORMAN WM: Malignant hyperthermia: description and case report. J Foot Surg 21: 7, 1982.
124. HABER J, HAMMER DJ, BUTLER B: Malignant hyperthermia: a review and case report. JAPA 73: 422, 1983.
125. LOWE MK: Malignant hyperthermia, a surgeon's nightmare. J Foot Surg 24: 139, 1985.
126. ZANETTE G, ROBB N, ZADRA N, ET AL: Undetected central core disease myopathy in an infant presenting for clubfoot surgery. Pediatr Anesth 17: 380, 2007.
127. SHUAIB A, PAASUKE RT, BROWNELL KW: Central core disease: clinical features in 13 patients. Medicine 66: 389, 1987.
128. BLOCH EC, GINSBERG B, BINNER RA, ET AL: Limb tourniquets and central temperature in anesthetized children. Pediatr Anesth 74: 486, 1992.
129. MOTEGI Y, SHIRAI M, ARAI M, ET AL: Malignant hyperthermia during epidural anesthesia. J Clin Anesthesia 8: 157, 1996.